Survey: 70% percent of developers rate diabetes highest for its market potential

Research2Guidance chart

Patients with chronic conditions remain the primary target group for mHealth app publishers, according to Research2Guidance’s findings. The survey involving 5,000 experts found that 70 percent of developers rate diabetes highest for its market potential over the next five years.

In 2012, however, obesity management solutions were thought to rival diabetes management solutions for their potential; three years later – just 38% of mHealth app practitioners rate obesity as the chronic disease with the highest business potential for mHealth apps. Hypertension (29%), depression (23%) and chronic heart diseases (16%) respectively have consistently ranked from third to fifth place in the rankings, and 2015 was no different. The remaining chronic diseases will remain niche markets over the coming years according to mHealth experts.

With the leading publisher currently expecting to see global download figures of over 30,000 per quarter, the market has become increasingly competitive. There are now more than 1,500 diabetes management solutions available to users, with leading developers opting to deliver solutions that sync with devices. Speaking of devices, those making them are also beginning to adopt solutions that allow users to easily export data, and this year we’ll see traditional device makers competing with app developers. At the end of the day, this will lead to more choice to the users and eventually help all apps become that much better.

Overall, the business potential preferences of mHealth app publishers haven’t changed in the past 5 years.